Literature DB >> 10564092

Vascular wall dysfunction in JCR:LA-cp rats: effects of age and insulin resistance.

S F O'brien1, J C Russell, S T Davidge.   

Abstract

We tested the hypothesis that aging and insulin resistance interact to increase vascular dysfunction by comparing the function of isolated mesenteric resistance arteries in obese, insulin-resistant JCR:LA-cp rats and lean, insulin-sensitive rats of the same strain at 3, 6, 9, and 12 mo of age. The peak constrictor responses to norepinephrine, phenylephrine, and high potassium were elevated in arteries from obese rats. Responses to these agents increased with age in both obese and lean rats. An eicosanoid constrictor contributed substantially to vasoconstriction in the arteries from both lean and obese animals. Inhibition of nitric oxide synthase increased the vasoconstrictor response to norepinephrine in both obese and lean rats. This effect increased with age in lean rats only. Vascular relaxation in response to acetylcholine and sodium nitroprusside was impaired in the obese rats and did not alter with age. The results suggest that obese JCR:LA-cp rats have enhanced maximal constriction, which originates in the arterial smooth muscle and increases with age. There is evidence that the ability of the arteries to compensate for the enhanced contractility is impaired in obese rats, particularly with advanced age.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10564092     DOI: 10.1152/ajpcell.1999.277.5.C987

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  4 in total

1.  A novel complex of arginine-silicate improves micro- and macrovascular function and inhibits glomerular sclerosis in insulin-resistant JCR:LA-cp rats.

Authors:  S D Proctor; S E Kelly; J C Russell
Journal:  Diabetologia       Date:  2005-07-01       Impact factor: 10.122

2.  Protection of vascular wall function in insulin-resistant rats from copper oxidative stress.

Authors:  S F O'Brien; S T Davidge; Y Zhang; J C Russell
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

3.  Irbesartan-mediated reduction of renal and cardiac damage in insulin resistant JCR : LA-cp rats.

Authors:  J C Russell; S E Kelly; D F Vine; S D Proctor
Journal:  Br J Pharmacol       Date:  2009-10-08       Impact factor: 8.739

4.  A clinical evaluation to determine the safety, pharmacokinetics, and pharmacodynamics of an inositol-stabilized arginine silicate dietary supplement in healthy adult males.

Authors:  Douglas S Kalman; Samantha Feldman; Adam Samson; Diane R Krieger
Journal:  Clin Pharmacol       Date:  2015-10-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.